Biological
Enriched Hematopoetic Stem Cell Infusion
Enriched Hematopoetic Stem Cell Infusion is a biological therapy with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
3
60%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Terminated(1)
Other(2)
Detailed Status
unknown2
Completed2
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 13 (100.0%)
Trials by Status
withdrawn120%
unknown240%
completed240%
Recent Activity
0 active trials
Showing 5 of 5
withdrawnphase_1
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
NCT01419704
unknown
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)
NCT02084121
completedphase_1
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
NCT00777231
unknown
Single Patient Expanded Access Protocol: Metabolic Boost
NCT02021266
completedphase_1
Induction of Donor Specific Tolerance in Recipients of Cardiac Allografts by Donor Stem Cell Infusion
NCT00497757
Clinical Trials (5)
Showing 5 of 5 trials
NCT01419704Phase 1
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
NCT02084121
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)
NCT00777231Phase 1
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
NCT02021266
Single Patient Expanded Access Protocol: Metabolic Boost
NCT00497757Phase 1
Induction of Donor Specific Tolerance in Recipients of Cardiac Allografts by Donor Stem Cell Infusion
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5